Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

Katalin Boér; István Láng; Antonio Llombart-Cussac; Inger Andreasson; Guillermo L. Vivanco; Nick Sanders; Gillian M. Pover; Elizabeth Murray

doi:10.1007/s10637-010-9538-8

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

Investigational New Drugs ◽

10.1007/s10637-010-9538-8 ◽

2010 ◽

Vol 30 (2) ◽

pp. 681-687 ◽

Cited By ~ 28

Author(s):

Katalin Boér ◽

István Láng ◽

Antonio Llombart-Cussac ◽

Inger Andreasson ◽

Guillermo L. Vivanco ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Second Line ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii

Download Full-text

Vinorelbine as second line treatment in anthracycline pre-treated advanced breast cancer patients: A phase II study

European Journal of Cancer ◽

10.1016/0959-8049(93)91052-m ◽

1993 ◽

Vol 29 ◽

pp. S82 ◽

Cited By ~ 4

Author(s):

L. Dogliotti ◽

G. Gorzegno ◽

M.G. Bau ◽

A. Farris ◽

C. Bumma ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Second Line ◽

Breast Cancer Patients

Download Full-text

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

10.1158/1538-7445.am2014-ct101 ◽

2014 ◽

Cited By ~ 23

Author(s):

Richard S. Finn ◽

John P. Crown ◽

Istvan Lang ◽

Katalin Boer ◽

Igor M. Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Cyclin Dependent Kinase ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer

British Journal of Cancer ◽

10.1038/bjc.1995.496 ◽

1995 ◽

Vol 72 (5) ◽

pp. 1256-1258 ◽

Cited By ~ 13

Author(s):

RV Iaffaioli ◽

A Tortoriello ◽

G Facchini ◽

M Santangelo ◽

G De Sena ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Second Line

Download Full-text

Exploratory biomarker analysis in patients treated with vinorelbine plus everolimus or vinorelbine monotherapy as second-line treatment for HER2-negative advanced breast cancer: Final results from the randomized phase II trial VicTORia

Annals of Oncology ◽

10.1093/annonc/mdy272.285 ◽

2018 ◽

Vol 29 ◽

pp. viii94

Author(s):

T. Decker ◽

A. Mündlein ◽

N. Marschner ◽

A. Welt ◽

T. Riedt ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Line Treatment ◽

Second Line ◽

Randomized Phase Ii ◽

Biomarker Analysis

Download Full-text

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

Breast Cancer Research ◽

10.1186/s13058-020-01319-1 ◽

2020 ◽

Vol 22 (1) ◽

Author(s):

Laura Biganzoli ◽

Saverio Cinieri ◽

Rossana Berardi ◽

Rebecca Pedersini ◽

Amelia McCartney ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Older Women ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Cited By ~ 1

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90072-3 ◽

2003 ◽

Vol 1 (5) ◽

pp. S15-S16

Author(s):

P. Wimberger ◽

R. Kimmig ◽

F. Hilpert ◽

A. Stähle ◽

A. Burges ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Study Group ◽

Line Treatment ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Study Group ◽

Randomized Phase Ii

Download Full-text

A randomized phase II study of pemetrexed-carboplatin and gemcitabine-vinorelbine in patients with anthracycline- and taxane-pretreated advanced breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.1051 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 1051-1051 ◽

Cited By ~ 1

Author(s):

D. Amadori ◽

I. La Torre ◽

E. M. Carrasco ◽

S. Roesel ◽

R. Labianca ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Randomized Phase Ii

Download Full-text

Abstract P1-14-01: Final results of NorBreast-231, a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel as first-line chemotherapy in patients with advanced breast cancer

10.1158/1538-7445.sabcs18-p1-14-01 ◽

2019 ◽

Author(s):

MS Aapro ◽

R Hegg ◽

M Ruiz Borrego ◽

E Staroslawska ◽

S Morales ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-2377 ◽

2007 ◽

Vol 13 (12) ◽

pp. 3652-3659 ◽

Cited By ~ 23

Author(s):

Antonio Llombart-Cussac ◽

Miguel Martin ◽

Nadia Harbeck ◽

Rodica M. Anghel ◽

Alexandra E. Eniu ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Double Blind ◽

Line Chemotherapy

Download Full-text